Evidence map›Paper›PMID 40008148›Full record

ArticleFrontiers in public health2025

Differences in HIV infection trends in two regions of Cameroon with a longstanding HIV epidemic: insights from 2012 and 2022.

Yannick F Ngoume, Urmes C Teagho, Brice Eselacha, Oumarou H Goni, Dell-Dylan Kenfack, Mérimé Tchakoute, Georges Nguefack-Tsague, Marcel Tongo

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yannick F NgoumeCentre of Research for Emerging and Re-Emerging Diseases/Institute of Medical Research and Studies of Medicinal Plants (CREMER/IMPM), Yaoundé, Cameroon.
Urmes C TeaghoCentre of Research for Emerging and Re-Emerging Diseases/Institute of Medical Research and Studies of Medicinal Plants (CREMER/IMPM), Yaoundé, Cameroon.
Brice EselachaMinistry of Scientific Research and Innovation National Institute of Cartography (INC), Yaoundé, Cameroon.
Oumarou H GoniCentre of Research for Emerging and Re-Emerging Diseases/Institute of Medical Research and Studies of Medicinal Plants (CREMER/IMPM), Yaoundé, Cameroon.
Dell-Dylan KenfackCentre of Research for Emerging and Re-Emerging Diseases/Institute of Medical Research and Studies of Medicinal Plants (CREMER/IMPM), Yaoundé, Cameroon.
Mérimé TchakouteProgrammes de Santé et Développement au Sein du Groupement de la Filière Bois du Cameroun (GFBC), Yaoundé, Cameroon.
Georges Nguefack-Tsague *Faculty of Medicine and Biomedical Sciences, The University of Yaoundé I, Yaoundé, Cameroon.
Marcel Tongo *Centre of Research for Emerging and Re-Emerging Diseases/Institute of Medical Research and Studies of Medicinal Plants (CREMER/IMPM), Yaoundé, Cameroon.

Funding

Gates Foundation INV-033558Wellcome Trust
6 · The paper itself

Abstract

Introduction: To achieve the UNAIDS 95-95-95 target by 2025, it is of great importance to test and diagnose individuals infected with HIV; especially those residing in communities with limited access to health and in areas with a longstanding HIV epidemic, where the virus has been circulating since the early phase of the pandemic. In this regard, we determined the HIV prevalence in remote communities of the East and South administrative regions of Cameroon where the four cross-species SIV transmissions that gave rise to the four HIV-1 groups likely happened. Methods: We did this in two different periods: 2012/2013 (Period 1; 4,435 participants enrolled in the East and 2,347 in the South) and 2021/2022 (Period 2; 2,203 participant enrolled in the East and 2,347 in the South) using HIV1/2 rapid assays and standard ELISAs and according to the WHO testing strategy. Results: During Period 1, the HIV seroprevalence in the East was 6.9%. This prevalence had significantly decreased to 2.7% [Prevalence Difference or PD: 4.1 (3.1; 5.2); Conclusion: Our data suggest that HIV transmission in remote communities of the South administrative region of Cameroon has likely remained uncurbed over the past decade. As a result, this region should be prioritized in efforts to curb the spread of HIV and reduce its prevalence.

Indexed as

EpidemicsHIV InfectionsAdolescentAdultCameroonFemaleHIV SeroprevalenceHumansMaleMiddle AgedPrevalenceYoung AdultCameroonHIV diagnosisHIV diversityHIV infectionHIV prevalence

Identifiers

PMID40008148
PMCPMC7617435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.